Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Bajaj Healthcare standalone net profit declines 17.90% in the March 2022 quarter

Bajaj Healthcare (BHL) rose 4.50% to Rs 390.30 after the company announced that it has launched Magnesium L-Threonate in nutraceutical segment.

Bajaj Healthcare gallops on launching new product

Here’s what Gaurav Sharma of Globe Capital Markets, recommends investors should do with these stocks when the market resumes trading today.

Trade Spotlight | What Should You Do With MCX India, Bajaj Healthcare, Biocon And Polyplex Corporation?

Motor Gen Fin, Rajdarshan Ind, Bajaj Healthcare, Rel Ind Infra and IFCI, hit their fresh 52-week highs during the day.

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Sarthak Metals, Bajaj Healthcare, Dhruv Consultancy, R Systems Intnl and Latent View Analytics Ltd., hit their fresh 52-week highs during the day.

Sarthak Metals, Bajaj Healthcare, Dhruv Consultancy, Latent View Analytics Ltd. and R Systems Intnl, hit their fresh 52-week highs at 10:50AM.

Stock market update: Stocks that hit 52-week highs on NSE

Over the next 2-3 years, the management is targeting a top line of over Rs 1,000 crore, which equates to a CAGR revenue growth of around 18-20 percent

Bajaj Healthcare: Correction Presents Buying Opportunity

Bajaj Healthcare standalone net profit declines 14.26% in the September 2021 quarter

The company launched 2-Deoxy-D-Glucose formulation ‘DGJAJ’, for the treatment of moderate to severe COVID-19.

Bajaj Healthcare commences production of DGJAJ; Stock jumps over 2%

Reliance, HCG, HFCL, ICICI Lombard, Dr Reddy’s, Engineers India, Tourism Finance, Bajaj Healthcare to remain in focus

Stocks that will see action today

2-DG can be administered only upon prescription and under the supervision of a qualified physician to hospitalised Covid-19 patients with moderate to severe infection as an adjunct therapy

Bajaj Healthcare launches Covid treatment drug 2-DG under brand name ‘DGJAJ’

Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of bulk drugs and pharmaceutical products. The Company's segments include manufacturing of Bulk Drugs, and Formulation and sale of medicines. 

Bajaj Healthcare Ltd

Bajaj Healthcare Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Bajaj Healthcare standalone net profit declines 17.90% in the March 2022 quarter

Bajaj Healthcare gallops on launching new product

Trade Spotlight | What Should You Do With MCX India, Bajaj Healthcare, Biocon And Polyplex Corporation?

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Stock market update: Stocks that hit 52-week highs on NSE

Bajaj Healthcare: Correction Presents Buying Opportunity

Bajaj Healthcare standalone net profit declines 14.26% in the September 2021 quarter

Bajaj Healthcare Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Bajaj Healthcare standalone net profit declines 17.90% in the March 2022 quarter

Bajaj Healthcare gallops on launching new product

Trade Spotlight | What Should You Do With MCX India, Bajaj Healthcare, Biocon And Polyplex Corporation?

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Stock market update: Stocks that hit 52-week highs on NSE in today’s trade

Stock market update: Stocks that hit 52-week highs on NSE

Bajaj Healthcare: Correction Presents Buying Opportunity

Bajaj Healthcare standalone net profit declines 14.26% in the September 2021 quarter

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock